The two men were tried in absentia as Pakistan did not force them to appear at the high-security trial as requested by the Netherland
Pfizer said on Monday its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults aged 18 and older with a compromised immune system.
A single 120 microgram dose of the vaccine generated strong neutralising antibodies against both subtypes of RSV, called RSV-A and RSV-B, across all groups in the study, Pfizer said.
Abrysvo was well-tolerated in the study and showed a safety profile consistent with findings from other studies of the vaccine, it added.
The drugmaker plans to submit the data to regulatory agencies for review.
The study tested two doses of Abrysvo in 203 adults across four groups - those with a type of lung cancer, end-stage kidney disease, autoimmune inflammatory disorder, and solid organ transplant recipients - all of whom have compromised immunity and are at risk of developing severe RSV-associated disease.
Pfizer's vaccine is currently approved for people aged 60 and older and for use in women during the middle of the third trimester of pregnancy to protect their babies.
RSV typically causes cold-like symptoms but is also a leading cause of pneumonia in toddlers and older adults, leading to 177,000 hospitalisations and 14,000 deaths in the United States annually.
The two men were tried in absentia as Pakistan did not force them to appear at the high-security trial as requested by the Netherland
When Sheikh Khaled planted sapling at Rajghat, it was special; here's why
52,000 Gazan children would have started first grade on Monday
Historian Allan Lichtman reveals his much-discussed, once-every-four-years White House prediction, based on what he calls the '13 keys' method
A massive television audience is expected to tune in on Tuesday to watch Harris go toe to toe with Trump over what both are calling the most important election of modern times
This was one of the most violent attacks in years, according to Britain-based Observatory chief Rami Abdel Rahman
The elections are the first to be held under a law passed in January 2022 that increased the overall number of seats in the house, reserved a higher number for women and lowered the minimum age for candidates
Turk sees the need to change paths to avoid a future filled with military escalation, repression, disinformation, deepening inequality and rampant climate change